SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-028305
Filing Date
2023-04-07
Accepted
2023-04-07 16:30:16
Documents
13
Period of Report
2023-04-03
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea176568-8k_phoenix.htm   iXBRL 8-K 33689
  Complete submission text file 0001213900-23-028305.txt   262097

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE pbax-20230403.xsd EX-101.SCH 4365
3 XBRL DEFINITION FILE pbax-20230403_def.xml EX-101.DEF 27266
4 XBRL LABEL FILE pbax-20230403_lab.xml EX-101.LAB 37797
5 XBRL PRESENTATION FILE pbax-20230403_pre.xml EX-101.PRE 25886
7 EXTRACTED XBRL INSTANCE DOCUMENT ea176568-8k_phoenix_htm.xml XML 7060
Mailing Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103 2157319450
PHOENIX BIOTECH ACQUISITION CORP. (Filer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40877 | Film No.: 23809016
SIC: 6770 Blank Checks